Avoiding late meals and allowing time for digestion before lying down can help reduce acid reflux and heartburn
Determination of reduced homocysteine in human serum by elemental labelling and liquid chromatography with ICP-MS and ESI-MS detection
Choice of peptide in research depends on the target pathway and study goals
Low levels of Glutathione have been linked to neurodegenerative and cardiovascular diseases
By Product: Ozempic dominates, Tirzepatide products growing fastest Ozempic (semaglutide 0.5mg/1mg/2mg weekly subcutaneous injection) dominated the GLP-1 receptor agonist market with approximately 35.12% market share in 2025, driven by its combination of robust clinical efficacy data, early market entry, broad diabetes label, established prescriber relationships, and expanded off-label use for weight management before Wegovy's commercial scale-up
Peptides have become increasingly popular in recent years, driven by the stratospheric rise of injectable GLP-1s for weight loss and a fleet of gray market peptides claiming to help with post-workout recovery, hormone balance, hair loss, and skin health